norfloxacin has been researched along with rifamycins in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellot, P; Gómez-Hurtado, I; Ramos, JM; Such, J; Vidal, I; Zapater, P | 1 |
| Abdallah, M; Badra, G; Mostafa, T | 1 |
| Abdelaziz, A; Abdelrashed, M; Assem, M; El-Azab, G; Elemam, S; Elsabaawy, M; Hamed, W; Khodeer, S | 1 |
| Abd-Elsalam, S; Abo Ali, L; Elfert, A; Ibrahim, S; Soliman, S | 1 |
3 trial(s) available for norfloxacin and rifamycins
| Article | Year |
|---|---|
The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
Topics: Adult; Anti-Bacterial Agents; Ascites; Bacterial Infections; Female; Humans; Interleukin-10; Interleukin-6; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Random Allocation; Rifamycins; Rifaximin; Single-Blind Method; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Drug Administration Schedule; Female; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome | 2016 |
Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ascites; Bacterial Infections; Cause of Death; Egypt; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Mortality; Norfloxacin; Peritonitis; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome | 2016 |
1 other study(ies) available for norfloxacin and rifamycins
| Article | Year |
|---|---|
Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Liver Cirrhosis; Microbial Sensitivity Tests; Norfloxacin; Rifamycins; Rifaximin | 2016 |